LifeMD, Inc. (LFMD) Tops Q3 EPS by 18c

LifeMD, Inc. (NASDAQ: LFMD) reported Q3 EPS of ($0.03), $0.18 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.85 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
• Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
• Revvity to acquire Human Cell Design in metabolic disease research deal